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A B S T R A C T
Secondary bile acids promote gastrointestinal (GI) tract permeabilization both in vivo and in vitro. Consumption
of high fat diets increases bile acid levels in the GI tract which can contribute to intestinal permeabilization and
consequent local and systemic inflammation. This work investigated the mechanisms involved in bile acid
(deoxycholic acid (DCA))-induced intestinal epithelial cell monolayer permeabilization and the preventive ca-
pacity of (-)-epicatechin (EC). While EC prevented high fat diet-induced intestinal permeabilization in mice, it
did not mitigate the associated increase in fecal/cecal total and individual bile acids. In vitro, using differentiated
Caco-2 cells as a model of epithelial barrier, EC and other NADPH oxidase inhibitors (VAS-2870 and apocynin)
mitigated DCA-induced Caco-2 monolayer permeabilization. While EC inhibited DCA-mediated increase in cell
oxidants, it did not prevent DCA-induced mitochondrial oxidant production. Prevention of DCA-induced ERK1/2
activation with EC, VAS-2870, apocynin and the MEK inhibitor U0126, also prevented monolayer permeabili-
zation, stressing the key involvement of ERK1/2 in this process and its redox regulation. Downstream, DCA
promoted myosin light chain (MLC) phosphorylation which was related to MLC phosphatase (MLCP) inhibition
by ERK1/2. DCA also decreased the levels of the tight junction proteins ZO-1 and occludin, which can be related
to MMP-2 activation and consequent ZO-1 and occludin degradation. Both events were prevented by EC, NADPH
oxidase and ERK1/2 inhibitors. Thus, DCA-induced Caco-2 monolayer permeabilization occurs mainly secondary
to a redox-regulated ERK1/2 activation and downstream disruption of TJ structure and dynamic. EC's capacity to
mitigate in vivo the gastrointestinal permeabilization caused by consumption of high-fat diets can be in part
related to its capacity to inhibit bile-induced NADPH oxidase and ERK1/2 activation.
1. Introduction
Consumption of Western type diets high in saturated fats has dele-
terious consequences on the gastrointestinal (GI) tract. They include,
among others, a higher risk for colorectal cancer [1–3], altered in-
testinal immunity [4], inflammation [5], and intestinal permeabiliza-
tion [5–7]. In fact, an increased intestinal permeability and the asso-
ciated local and systemic inflammation can underlie several of high fat
diet- and obesity-associated morbidities [8,9].
The permeability of the GI tract is determined by the tight junction
(TJ), which connect a single layer of epithelial cells [10]. Intercellular
TJs are a complex of proteins including both integral (e.g. occludin,
claudins) and intracellular (e.g. ZO-1, ZO-2) proteins that are linked to
an actomyosin ring. TJs selectively allow the passage of water and ions
and restrict the paracellular transport of larger molecules. The unrest-
ricted intestinal passage of large molecules (e.g. pathogens, luminal
food and microbial toxins) can have direct systemic effects, activating
the GI immune system leading to local inflammation and the systemic
release of proinflammatory cytokines. Accordingly, a loss of intestinal
barrier integrity/function has been observed in several human pathol-
ogies [5].
Select bile acids increase GI permeability both in vivo and in vitro
models. Thus, the intestinal permeabilization observed in rats fed a
high-fat diet was found to be related to both the dietary fat itself and
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the associated increased intestinal levels of bile acids [11]. Deoxycholic
acid (DCA), a hydrophobic secondary bile acid, promotes the permea-
bilization of Caco-2 cell monolayers [12]. DCA affects the physical
properties of cell membrane domains [13], which is associated to the
activation of cell signals that regulate TJ permeability. In intestinal
epithelial cells DCA causes the activation of the epidermal growth
factor (EGF) receptor (EGFR) [13,14], and downstream the ERK1/2
signaling pathway [15]. Together with transcription factor NF-κB,
ERK1/2 upregulates myosin light chain (MLC) kinase (MLCK), a central
physiological modulator of TJ permeability [10,16,17]. Bile acids also
downregulate TJ proteins expression, which could contribute to DCA-
mediated barrier permeabilization [12]. Overall, the increased bile acid
production and luminal content required for fat absorption could ex-
plain the increased permeabilization of the GI tract observed with
consumption of high-fat diets.
Diet has a major role in the development and progression of GI-
associated pathologies. Among dietary factors, flavonoid-rich foods can
exert GI protective and trophic effects through different mechanisms
[18]. In particular, the flavan-3-ol (-)-epicatechin (EC) prevents in-
flammation- and high fat diet-induced intestinal permeabilization both
in vitro and in vivo [19,20]. In vitro, EC prevents tumor necrosis alpha
(TNFα)-induced permeabilization of Caco-2 cell monolayers through
the inhibition of NADPH oxidase, leading to a decrease in superoxide
production, and inactivation of the transcription factor NF-κB [19]. In
mice fed a high-fat diet, supplementation with EC prevented the in-
creased GI permeability and the associated endotoxemia [20].
An increase in luminal bile acids can in part underlie the increased
intestinal permeabilization associated with the consumption of diets
rich in fat content, contributing to the associated co-morbidities. On the
other hand, a diet rich in select bioactives (e.g. EC) could mitigate in-
testinal permeabilization by inhibiting bile-acid mediated barrier da-
mage. This work investigated the mechanisms involved in bile acid
(deoxycholic acid (DCA))-induced intestinal epithelial cell monolayer
permeabilization and the preventive capacity of EC. We initially studied
if the capacity of EC to prevent high fat diet-induced intestinal per-
meabilization in mice could occur through the modulation of bile acid
metabolism. Subsequently, and using Caco-2 cell monolayers as a model
of intestinal barrier, we investigated the potential capacity of EC to
prevent bile direct effects on the epithelium. The ERK1/2 signaling
pathway emerges as a central mechanism in DCA-induced monolayer
permeabilization. The protective action of EC is in part mediated by its
capacity to inhibit NADPH oxidase, oxidant production, and down-
stream ERK1/2 activation.
2. Materials and methods
2.1. Materials
Caco-2 cells were from the American Type Culture Collection
(ATCC, Rockville, MA). Cell culture media and reagents, 5-(and-6)-
carboxy-2′7′-dichlorodihydrofluorescein diacetate (DCFDA), MitoSOX
Red mitochondrial superoxide indicator (M36008), and primary anti-
bodies for ZO-1 (#339100), occludin (#331500), claudin-1 (#717800),
and claudin-2 (#325600) were from Invitrogen/Life Technologies
(Grand Island, NY). U0126 (#9903) and primary antibodies for
phospho-p44/42 ERK1/2 (Thr202/Tyr204) (#4370), p44/42 ERK1/2
(#4695), phospho-p65 (Ser536) (#3033), p65 (#8242), phospho-MLC
2 (Ser19) (#3671), MLC 2 (#8505), phospho-MYPT1 (Thr696)
(#5163); MYPT1 (#8574), phospho-EGFR (Tyr1068) (#3777), EGFR
(#4267), and β-actin (#12620) were from Cell Signaling Technology
(Danvers, MA). DCA, EC, apocynin, VAS-2870, FITC-dextran, and di-
hydroethidium (DHE) were from Sigma Chem. Co. (St. Louis, MO). The
Amplex® Red Hydrogen Peroxide/Peroxidase Assay Kit was from
Thermo Fisher Scientific (Waltham, MA).
2.2. Animals and animal care
All procedures conducted during this study were in agreement with
standards for the care of laboratory animals as outlined in the NIH
Guide for the Care and Use of Laboratory Animals. All procedures were
administered under the auspices of the Animal Resource Services of the
University of California, Davis. Experimental protocols were approved
before implementation by the University of California, Davis Animal
Use and Care Administrative Advisory Committee.
Healthy male C57BL/6J mice (20–25 g) (7 mice/group) were di-
vided into 2–3 mice per cage, housed at 21–22 °C and 53–55% humidity
on a 12-h light-dark cycle. They were fed for 15 weeks either: A-a diet
containing approximately 10% total calories from fat (Control)
(TD.06416, Harlan Laboratories, Madison, WI), B- a diet containing
approximately 60% total calories from fat (lard) (HF) (TD.06414,
Harlan Laboratories, Madison, WI), and C- the high fat diet supple-
mented with 20mg EC/kg body weight (HFE) as previously described
[20]. The EC-containing diet was prepared every two weeks to account
for changes in body weight and food intake, and to prevent potential EC
degradation. All diets were stored at −20 °C until use. Details on me-
tabolic parameters and in vivo evaluation of intestinal permeability for
this animal study have been previously published [20]. After 15 weeks
on the dietary treatments, mice were euthanized by cervical disloca-
tion. The cecum content and feces were collected and stored at−80 °C
until analysis for bile acid content.
2.3. Determination of total and individual bile acids
For total bile acid content determination, feces were weighed and
dried in an oven at 37 °C for 24 h. Samples were subsequently powdered
using a mortar, and bile acids were hydrolyzed under alkaline condi-
tions at 220 °C. Subsequently, samples were neutralized with 12 N HCl,
followed by three extractions in diethyl ether, as previously described
[21,22]. Total bile acids were measured using a 3-α hydroxysteroid
dehydrogenase assay kit (Crystal Chem, Inc., IL, USA).
For individual bile acid analysis, mice cecum samples (20mg) were
homogenized in 1ml of 70% (v/v) methanol containing 25 μl of 40 μg/
ml d4 (deuterated)-DCA for 30 s at 6,000 rpm on a Precellys homo-
genizer (Bertin Technologies, UK). The slurry was then centrifuged at
1,000×g at 4 °C and the supernatant transferred to a new tube and
added with 25 μl of 40 μg/ml d4-chenodeoxycholic acid. Samples were
concentrated by centrifugal evaporation at 50 °C for 70min to almost
dryness using a SpeedVac™ concentrator, and then brought to 1ml
volume with 5% (v/v) methanol and added with 25 μl of 40 μg/ml d4-
cholic acid. The reconstituted samples were passed through a hydro-
philic-lipophilic balance clean-up cartridge (Waters Oasis Prime HLB,
1ml, 30mg), washed with 1ml of 5% (v/v) methanol and eluted in
500 μl methanol added with 25 μl of 40 μg/ml d4-glycholic acid and d4-
lithocholic acid. Of the internal standards added, d4-glycholic acid was
the primary reference internal standard, with the others monitored as
checks in the extraction procedure. The final sample was submitted for
analysis by LC-MS/MS using an Agilent 1260 binary HPLC coupled to
an AB Sciex 4000 QTrap triple quadrupole mass spectrometer. HPLC
was carried out using a binary gradient of solvent A (water + 5 mM
ammonium acetate + 0.012% (v/v) formic acid) and solvent B
(methanol + 5 mM ammonium acetate + 0.012% (v/v) formic acid) at
a constant flow rate of 600 μl/min. Separation was achieved using a
Supelco Ascentis Express C18 150 × 4.6, 2.7 μm column maintained at
40 °C. The mass spectrometer was operated in electrospray negative
mode with capillary voltage of 4500V at 550 °C. Instrument specific gas
flow rates were 25ml/min curtain gas, GS1: 40ml/min and GS2:
50ml/min. Mass fragmentation was monitored in MRM mode.
Quantification was applied using Analyst 1.6.2 software to integrate
detected peak areas relative to the deuterated internal standards.
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2.4. Cell culture and incubations
Caco-2 cells were cultured at 37 °C and 5% (v/v) CO2 atmosphere in
minimum essential medium (MEM) supplemented with 10% (v/v) fetal
bovine serum and antibiotics (50 U/ml penicillin, and 50 μg/ml strep-
tomycin). For the experiments, cells seeded in semipermeable mem-
branes or in regular dishes were differentiated for 18–21 or 9–12 days,
respectively, after confluence. The cell culture medium was replaced
every 3 days. Cells were then incubated in the absence or the presence
of 100 μM DCA, with or without EC (1–10 μM), 1 μM apocynin, 1 μM
VAS-2870, and 10 μM U0126, for the time period indicated for each
experiment. After the corresponding incubations, the medium was
collected for matrix metalloproteinase (MMP) determination, and cells
collected and processed accordingly for the different determinations.
2.5. Cell viability
Cell viability was evaluated using the MTT (3-[4,5-dimethylthiazol-
2-yl]-2,5 diphenyl tetrazolium bromide) assay which is based on the
conversion of MTT into formazan crystals by living cells. Cells were
treated with DCA and/or EC as described above, and at the end of the
incubation cells were added with a 0.5mg/ml MTT solution in PBS.
After 2 h of incubation at 37 °C, the reaction was stopped by addition of
DMSO, and plates were incubated overnight. Absorbance (λ
570–690 nm) was measured using a BioTek Synergy H1 plate reader
(BioTek Instruments, Winooski, VT) and expressed as percentage of
untreated (control) cell values.
2.6. Transport of fluorescein isothiocyanate-dextran (FITC-dextran)
Cells were differentiated into polarized monolayers by culture on
transwell inserts (12mm, 0.4 μm pore polyester membranes) placed in
24-well plates at a seeding density of 0.3× 106 cells/transwell. The
volume of medium added to the upper and lower compartments was
400 μl and 600 μl, respectively. The paracellular transport through
Caco-2 cell monolayers was determined by measuring the apical-to-
basolateral clearance of FITC-dextran (4 kDa). DCA (100 μM) and EC
(1–10 μM), the NADPH oxidase inhibitors apocynin and VAS-2870
(1 μM) or U0126 (10 μM) were added to the apical compartment. FITC-
dextran was subsequently added to this compartment (100 μg/ml final
concentration), and 100 μl of the medium in the lower compartment
were collected every hour for 4 h. Aliquots were diluted with 100 μl of
MEM without phenol red, and the fluorescence was measured at λexc:
485 nm and λem: 530 nm in a plate reader (Biotek Synergy H1 plate
reader, BioTek Instruments, Winooski, VT). The FITC-dextran clearance
(CLFITC) was calculated using the equation fFITC/(FFITC/A), where fFITC is
flux of FITC-dextran (in fluorescence units/h); FFITC, the fluorescence of
FITC-dextran in the upper compartment at zero time (in fluorescence
units per nl); and A, the surface area of the membrane (1 cm2).
Arbitrary units (AU) were calculated based on the CLFITC value for the
non-added (control) cells which showed a mean CLFITC= 75 nl/h/cm2.
2.7. Cell oxidant levels
Cell oxidant levels were estimated using the probes DCFDA, DHE
and Amplex® Red. DCFDA and DHE enter cells, and when oxidized are
converted into fluorescent compounds. Caco-2 cells were grown and
differentiated in 96 well plates. Cells were incubated for 0.5–4 h in the
absence or presence of 100 μM DCA with or without the addition of
5 μMEC. At the corresponding times, cells were added with 20 μM
DCFDA or 10 μM DHE, and after 30min incubation the medium was
removed, cells rinsed with PBS, and fluorescence measured, for oxi-
dized DCFDA at λexc: 485 nm; λem: 535 nm, and for oxidized DHE at
λexc: 485 nm; λem: 535 nm. To normalize for the number of cells,
DCFDA and Amplex® Red fluorescence was referred to the DNA content
measured with propidium iodide as previously described [19], and DHE
fluorescence was referred to protein content. H2O2 released to the
medium was measured at the corresponding time points with the Am-
plex® Red Hydrogen Peroxide/Peroxidase Assay Kit following the
manufacturer's protocol.
2.8. Mitochondria oxidant production
Mitochondria oxidants production was determined using the
MitoSOX Red reagent, which is oxidized in the mitochondria mainly by
superoxide, and exhibits red fluorescence. Caco-2 cells were grown and
differentiated in 24 well plates. Cells were incubated for 0.5–4 h in the
absence or presence of 100 μM DCA with or without the addition of
5 μMEC. Cells were dissociated by treatment with trypsin, washed once
with PBS and the pellet resuspended in 0.4ml PBS containing 5 μM
MitoSOX Red (from a 5mM reagent stock solution prepared in DMSO).
Cells were subsequently incubated for 30min at room temperature,
protected from light. Appropriate controls were prepared: a positive
control incubated with Antimycin A (20 μM), known to produce a burst
of superoxide (and therefore an increase in MitoSOX fluorescence), and
a negative control of cells incubated in the absence of MitoSOX. Cell
fluorescence was measured in a FACSCanto II Flow Cytometer (BD
Biosciences, San Jose, CA). Data were acquired by CellQuest Software
(BD Biosciences, San Jose, CA) and analyzed using FlowJo (BD
Biosciences, San Jose, CA).
2.9. RNA isolation and real-time PCR (RT-PCR)
For quantitative RT-PCR studies, RNA was extracted from cells
using TRIzol reagent (Invitrogen, Carlsbad, CA). cDNA was generated
using high-capacity cDNA Reverse Transcriptase (Applied Biosystems,
Grand Island, NY). Expression of NOX1, NOX4, MLCK and β-actin was
assessed by quantitative real-time PCR (iCycler, Bio-Rad, Hercules, CA)
with the following primers:
Primer NOX1 Forward: 5′-GTACAAATTCCAGTGTGCAGACCAC-3′
Primer NOX1 Reverse: 5′-GTACAAATTCCAGTGTGCAGACCAC-3′
Primer NOX4 Forward: 5′-CTCAGCGGAATCAATCAGCTGTG-3′
Primer NOX4 Reverse: 5′-AGAGGAACACGACAATCAGCCTTAG-3′
Primer MLCK Forward: 5′-GAGGTGCTTCAGAATGAGGACG -3′
Primer MLCK Reverse: 5′- GCATCAGTGACACCTGGCAACT -3′
Primer β-Actin Forward: 5′-TCATGAAGTGTGACGTGGACATCCGC-3′
Primer β-Actin Reverse: 5′-CCTAGAAGCATTTGCGGTGCACGATG-3′
2.10. Western blot analysis
Total fractions were prepared as previously described [15]. Protein
concentration was measured [23] and aliquots containing 25–100 μg
protein were separated by reducing 10% (w/v) polyacrylamide gel
electrophoresis and electroblotted to PVDF membranes. Colored
(Biorad Laboratories, Hercules, CA) and biotinylated (Cell Signaling
Technologies, Danvers MA) molecular weight standards were ran si-
multaneously. Membranes were blotted for 1 h in 5% (w/v) non-fat
milk, incubated overnight in the presence of the corresponding anti-
bodies (1:1,000 dilution) in 5% (w/v) bovine serum albumin in TBS
buffer (50mM Tris, 150mM NaCl, pH 7.6), containing 0.1% (v/v)
Tween-20. After incubation for 90min at room temperature in the
presence of the secondary antibody (HRP-conjugated) (1:10,000 dilu-
tion) the conjugates were visualized by chemiluminescence detection in
a Phosphoimager 840 (Amersham Pharmacia Biotech. Inc., Piscataway,
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NJ).
2.11. Detection of matrix metalloproteinases by gelatin zymography
Analysis of MMPs gelatinolytic activity was performed using 7.5%
(w/v) polyacrylamide gels impregnated with 0.1% (w/v) gelatin. After
2 h incubation in the corresponding conditions, same volumes of
medium were collected from all wells, samples were centrifuged at
800×g for 8min to eliminate cell debris, and concentrated 7X using a
Vacufuge concentrator (Eppendorf, Germany). Non-reducing sample
buffer was added to 75 μl of the concentrated medium, and proteins
were separated by SDS-PAGE. Gels were washed 3 times in washing
buffer (2.5% (v/v) Triton X-100, 50mM Tris-HCl pH 7.5, 5 mM CaCl2,
1 μM ZnCl2) for 20min at room temperature to remove the SDS. Gels
were subsequently equilibrated with incubation buffer (1% (v/v) Triton
X-100, 50mM Tris-HCl pH 7.5, 5 mM CaCl2, 1 μM ZnCl2) for 10min at
37 °C, which was subsequently replaced with fresh buffer, and gels in-
cubated for 24 h at 37 °C. Gels were stained with Coomassie Brilliant
Blue R-250 (Biorad Laboratories, Hercules, CA) overnight, and de-
stained in a solution containing 10% (v/v) acetic acid and 40% (v/v)
methanol, until the gelatinase activity was clearly seen. Bands were
visualized in MyECL Imager (Thermo Scientific, New York, NY, USA).
2.12. Statistical analysis
All values are shown as means ± standard error of the means
(SEM). Data were analyzed by one-way analysis of variance (ANOVA)
using GraphPad Prism 7.0 (GraphPad Software, San Diego, CA, USA).
Fisher least significance difference test was used to examine differences
between group means. A p value < 0.05 was considered statistically
significant.
3. Results
3.1. Bile acid profiles in mice fed a high-fat diet: effects of EC
We previously observed that EC prevents high-fat diet-triggered
intestinal permeabilization [20]. In the same group of C57BL/6J mice,
consumption of the high-fat diet for 14 weeks led to a significant
(p < 0.05) increase in total fecal bile acids compared to levels found in
mice fed the control diet (Fig. 1A). Dietary supplementation with EC
(20mg/kg body weight) did not affect high-fat diet-mediated increase
in total fecal bile acid levels (Fig. 1A). Cecal unconjugated and con-
jugated bile acids were subsequently characterized by HPLC-MS in
MRM mode (Fig. 1B–E). Compared to controls, consumption of the
high-fat diet caused significantly higher levels of cecal β-muricholic
acid, cholic acid, deoxycholic acid, taurochenodeoxycholic acid, gly-
cholic acid, taurodeoxycholic acid and glycohyodeoxycholic acid. EC
supplementation did not prevent those increases (Fig. 1B–E).
3.2. EC prevents DCA-induced Caco-2 cell monolayer permeabilization
We next investigated if EC could inhibit DCA-induced monolayer
permeabilization of human Caco-2 cells differentiated into intestinal
epithelial cells. Under the experimental conditions used (100 μM DCA
and/or 1–10 μMEC) and upon 4 h incubation, neither DCA nor EC af-
fected cell viability (Fig. 2A). Changes in monolayer permeability were
evaluated by measuring the paracellular transport of the fluorescent
probe FITC-dextran (Fig. 2B–D). DCA (100 μM) caused a time (0–4 h)-
dependent increase in FITC-dextran transport from the upper to the
lower chamber (Fig. 2B). EC (1–10 μM) inhibited DCA-mediated in-
crease in FITC-dextran clearance at 2 h (Figs. 2C) and 3 h (data not
shown). After 4 h incubation, 1 μMEC had no effects while 5 and
10 μMEC inhibited DCA-induced increase in FITC-dextran paracellular
transport (Fig. 2D).
3.3. DCA increases NADPH oxidase expression and ROS production: effects
of EC
We previously observed that DCA-induced Caco-2 monolayer per-
meabilization was associated with increases in reactive oxygen species
(ROS) production [12,15]. EC has been shown to both inhibit NADPH
oxidase activation and prevent NOX1/NOX4 overexpression [20]. Thus,
we next investigated if the capacity of EC to prevent DCA-induced
permeabilization could be associated with the modulation of ROS
production, characterizing the two main ROS cellular sources, NADPH
oxidase and mitochondria.
NOX1 and NOX4 are the main NADPH oxidases present in Caco-
2 cells (data not shown). DCA did not affect NOX1 expression within the
studied period (0.5–4 h), while a significant increase in NOX4 mRNA
levels was observed after 3 and 4 h incubation with DCA (Fig. 3A). EC
(5 μM) prevented the increase in NOX4 expression after 3 h incubation
with DCA (Fig. 3B). Given that EC has been shown to also inhibit
NADPH activity we next assessed the capacity of EC to prevent DCA-
mediated increase in cellular ROS. This was assessed using three dif-
ferent probes; Amplex® Red, DCFDA and DHE. While Amplex® Red
fluorescence increase only reached significance after 4 h incubation
with DCA, DCA-induced DCFDA fluorescence increase was significant at
2 and 4 h and DHE fluorescence increase was significant at 0.5, 1 and
4h (Fig. 3C). EC prevented DCA-mediated increases in oxidant pro-
duction at all time points for the three probes used (data not shown).
Fig. 3D shows EC inhibition of ROS increase at the corresponding time
points of highest DCA effect, i.e. 4 h for Amplex® Red and DCFDA
fluorescence (12 and 75% higher in DCA-treated than in control cells,
respectively) and 30min for DHE fluorescence (45% higher in DCA-
treated than in control cells) (Fig. 3D).
DCA increased mitochondrial ROS production as evaluated by re-
action with MitoSOX and subsequent FACS (Fig. 3E–G). DCA caused a
significant increase in mitochondrial ROS production starting at 30min
incubation with DCA, which remained high for the following 3.5 h
(Fig. 3F). After 2 h incubation with DCA, MitoSOX fluorescence in-
creased to 2.1-fold over control values, and EC (5 μM) showed no pre-
ventive effects (Fig. 3G).
3.4. The ERK1/2 pathway is involved in DCA-induced Caco-2 cell
monolayer permeabilization: inhibition by EC and other NADPH oxidase
inhibitors
The redox-sensitive signals NF-κB and ERK1/2 are the main path-
ways controlling intestinal epithelium permeability. We next in-
vestigated the effects of DCA on the activation of NF-κB and ERK1/2 by
measuring the phosphorylation of p65 (Ser536) and ERK1/2 (Thr202/
Tyr204) by Western blot. p65 phosphorylation levels were not affected
by treatment with 100 μM DCA along a 4 h incubation period (Fig. 4A).
On the other hand, ERK1/2 phosphorylation significantly increased
(34–84%) within 1–4 h incubation with DCA, when compared to basal
levels. Upstream ERK1/2, DCA increased (100% over control values)
the activating phosphorylation (Tyr1068) of the EGFR, which was
prevented by EC (Fig. 4B). After 2 h incubation, EC (5 μM), apocynin
(1 μM) and VAS-2870 (1 μM), fully prevented DCA-mediated increase of
ERK1/2 phosphorylation (Fig. 4B and C).
To understand the role of ERK1/2 on DCA-induced Caco-2 mono-
layer permeabilization we inhibited the pathway with the MEK in-
hibitor U0126. At 10 μM concentration, U0126 not only fully inhibited
DCA-mediated increase in ERK1/2 phosphorylation, but values were
64% lower than basal levels (Fig. 4C). Stressing a central role of ERK1/
2 in the permeabilization induced by DCA, U0126 also prevented the
increase in FITC-dextran clearance (Fig. 4D). The NADPH oxidase in-
hibitors Apocynin and VAS-2870 were also effective inhibiting DCA-
mediated increase in ERK1/2 phosphorylation and permeabilization of
the monolayer (Fig. 4C and D).
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3.5. Effects of DCA on MLC phosphorylation: role of EC
Phosphorylation of MLC is a central mechanism involved in TJ
opening and barrier permeabilization. After 2 h incubation, DCA caused
a 30% increase in the levels of MLC phosphorylation at Ser19. EC
(5 μM), NADPH oxidase inhibitors (1 μM), and U0126 (10 μM) fully
inhibited this increase (Fig. 5A). MLC is phosphorylated in Thr19/Ser19
by MLCK and dephosphorylated by MLC phosphatase. To evaluate the
potential upregulation of MLCK by DCA, the mRNA levels of the kinase
were measured by RT-PCR. DCA cause a time-dependent decrease in
MLCK mRNA levels (Fig. 5B). After 2 h incubation, MLCK mRNA levels
were similar among the DCA-treated cells in both the absence and the
presence of the inhibitors (Fig. 5C). On the other hand, DCA caused a
significant increase (27%) in the phosphorylation levels of the MLC
phosphatase regulatory subunit MYPT1 at Thr696 (Fig. 5D). This in-
crease was prevented by EC (5 μM), NADPH oxidase inhibitors (1 μM),
and U0126 (10 μM).
3.6. DCA promotes the downregulation of tight junction proteins
The TJ is composed by several proteins including ZO-1, occludin
and claudins. To assess if DCA could act permeabilizing the Caco-2
monolayer by affecting the expression of TJ proteins, the protein con-
tent of ZO-1, occludin and claudin 1 and 2 were measured by Western
blot. DCA promoted a time-dependent decrease in ZO-1 and occludin
protein levels, while not affecting those of claudins 1 and 2 (Fig. 6A).
After 2 h incubation with DCA (100 μM), ZO-1 and occludin levels in
total cell homogenates were 24 and 25% lower than in control cells, and
this was prevented by co-incubation with EC (5 μM), apocynin (1 μM)
and VAS-2870 (1 μM) (Fig. 6B and C). U0126 (10 μM) fully prevented
the DCA-induced decreased expression of ZO-1, with a trend (p= 0.06)
inhibiting DCA-mediated occludin decrease.
Metalloproteinases can degrade TJ proteins. Thus, MMP-2 activity
was next measured in the cell culture medium by zymography. DCA
caused a 2.1-fold increase in MMP-2 activity over control values
(Fig. 6D). EC (5 μM), NADPH oxidase inhibitors (1 μM), and U0126
(10 μM) fully inhibited DCA-mediated MMP-2 activation.
4. Discussion
The capacity of EC to mitigate high fat diet-induced intestinal per-
meabilization in mice is not due to changes in bile acid metabolism, but
it can be in part attributed to the prevention of bile (DCA)-induced
barrier damage. DCA-induced Caco-2 cell monolayer permeabilization
occurred secondary to NADPH oxidase and ERK1/2 activation.
Permeabilization was paralleled by increased phosphorylation of MLC
due to the inhibition of the MLC phosphatase. DCA also decreased the
expression of the TJ proteins ZO-1 and occludin, which can be related
to their degradation by MMP-2. Stressing a central role for NADPH
oxidase in DCA-induced permeabilization, EC and other NADPH oxi-
dase inhibitors prevented DCA-mediated ERK1/2 activation and the
downstream events. Thus, the observed capacity of EC to inhibit
Fig. 1. Effects of a high-fat diet and of EC supplementation on fecal/cecal bile acid profiles in mice. Mice were fed a control diet (empty bars), a high-fat diet
(HF) (black bars), or the high-fat diet supplemented with 20mg EC/kg body weight (HFE) (blue bars). A- Total fecal bile acids and B-E- individual cecum bile acids
were measured as described in methods. Results are shown as means ± SEM and are the average of 5–7 animals/group. Values having different superscripts are
significantly different (p < 0.05, One-way ANOVA)
MCA: muricholic acid, CA: cholic acid, CDCA: chenodeoxycholic acid, DCA, deoxycholic acid; LCA: lithocholic acid, HDCA: hyodeoxycholic acid, UDCA: urso-
deoxycholic acid, T-α-MCA: tauro-α-muricholic acid, T-β-MCA: tauro-β-muricholic acid, TCA: taurocholic acid, TCDCA: taurochenodeoxycholic acid, THCA: taur-
ohyocholic acid, GCA: glycholic acid, GCDCA: glycochenodeoxycholic acid, TDCA: taurodeoxycholic acid, TLC: taurolithocholic acid, THDCA: taurohyodeoxycholic
acid, TUDCA: tauroursodeoxycholic acid, GDCA: glycohyodeoxycholic acid and GHDCA: glycohyodeoxycholic acid. (For interpretation of the references to color in
this figure legend, the reader is referred to the Web version of this article.)
Fig. 2. DCA causes an increase in Caco-
2 cell monolayer paracellular perme-
ability that is prevented by EC. Caco-
2 cell monolayers were treated with 100 μM
DCA in the absence or the presence of
0–10 μMEC added to the upper chamber
and cells incubated for 0–4 h. Caco-2 cell
monolayer permeability was evaluated by
measuring FITC-dextran paracellular trans-
port. A- Cell viability of Caco-2 cells treated
with DCA and in the absence or the pre-
sence of 1–10 μMEC for 6 h. B- Kinetics of
FITC-dextran paracellular transport in Caco-
2 monolayers in the absence of additions
(empty circles), and in the presence of
100 μM DCA without (black triangles) or
with (blue triangles) simultaneous addition
of 5 μM EC. *Significantly different from
controls at the corresponding time point.
C,D- Dose-dependent inhibition by EC of
DCA-induced FITC-dextran paracellular
transport after 2 h (C) or 4 h (D) incubation.
Results are shown as mean ± SEM of 5
independent experiments. A,C,D- Data were
normalized to control values. Values having
different superscripts are significantly dif-
ferent (p < 0.05, One-way ANOVA). (For
interpretation of the references to color in
this figure legend, the reader is referred to
the Web version of this article.)
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intestinal permeabilization in high fat-fed mice can be in part due to the
inhibition of bile acid-induced alterations in TJ structure/dynamics.
Excess levels of select bile acids could explain the increased in-
testinal permeability associated to the consumption of high-fat diets
[11,20,24]. The microbiota can contribute to this adverse effect given
that it undergoes major changes upon chronic high fat consumption,
and its central role in bile acid metabolism [25]. Thus, the microbiota
deconjugate and dehydroxylate bile acids produced in the liver and
secreted into the intestinal lumen, to generate unconjugated and sec-
ondary bile acids. While high-fat diet consumption caused major
changes in mouse fecal bile acid profiles, EC supplementation did not
affect neither total bile acid levels nor the individual types of bile acids.
In agreement with a lack of effect of EC on unconjugated and secondary
bile acids content, EC supplementation did not modify the altered mi-
crobiota profiles associated to the consumption of a high-fat diet [20].
On the other hand, the protective actions of EC on high-fat diet-induced
GI loss of barrier function in mice [20], could be due to EC capacity to
mitigate bile-induced intestinal monolayer permeabilization.
GI tract permeabilization can cause an increased paracellular
transport of bacterial endotoxins, which trigger local and systemic in-
flammation, contributing to the development of pathologies, including
insulin resistance, type 2 diabetes and cardiovascular diseases
[6,26,27]. The consumption of a high-fat diet per se, rather than the
associated obesity, have been proposed to trigger intestinal permeabi-
lization in rats [11]. In fact, the bile juice isolated from rats fed a high-
fat diet, as well as individual bile acids, promote permeabilization of
Caco-2 cell monolayers [11,19]. We observed that bile acids found at
largest amounts in the cecum from high fat-fed mice are muricholic
acids, cholic, and DCA. Among them, and also present in humans, DCA
causes permeabilization of intestinal monolayers [12] and is a major
player in pathologies associated to consumption of high-fat diets and
obesity [28].
In agreement with previous evidence [12], DCA caused the per-
meabilization of Caco-2 cells differentiated into a monolayer of in-
testinal epithelial cells, and EC prevented it. It is important to consider
that the use of Caco-2 cell monolayers as a model of intestinal epithe-
lium has limitations [29]. Among others, the Caco-2 cell population is
heterogeneous, the monolayer does not involve interactions of epithe-
lial cells with other cell types, and the model lacks a mucus layer.
However, the validity of the model for our study is supported by current
and previous observations on the capacity of EC to protect Caco-2
monolayers from permeabilization [19,20], which are in accordance
with the GI barrier protective effects exerted by dietary EC in high fat-
fed mice [20].
EC and the NADPH oxidase inhibitors apocynin and VAS-2870 in-
hibited DCA-mediated increase in paracellular transport. We previously
observed that the NADPH oxidase inhibitors apocynin and diphenyle-
neiodonium inhibited DCA-stimulated oxidant production in Caco-
2 cells [12]. Accordingly, we now observed that DCA increased NOX4
expression and cell oxidant levels, which were both prevented by EC.
Fig. 3. DCA causes an increase in Caco-
2 cell oxidant: effects of EC. Caco-2 cell
monolayers were treated with 100 μM DCA
in the absence or the presence of 5 μMEC
for 0–4 h. A,B- mRNA levels of NOX1 and
NOX4 were measured by RT-PCR and re-
ferred to β-actin mRNA content. mRNA le-
vels were measured A-between 0-4 h for
cells incubated without or with DCA, or B-
for 2 h without or with addition of DCA and
in the absence or the presence of 5 μMEC.
C- Kinetics (0–4 h) of oxidant production
evaluated using the probes Amplex® Red
(red circles), DCFDA (grey triangles), and
DHE (blue triangles) as described in
methods. D- Effects of DCA and 5 μMEC on
oxidant production as measured with
Amplex® Red (AR) after 1 h incubation, or
with DCFDA and DHE after 4 h incubation.
E-G- Mitochondrial oxidant production was
evaluated with MitoSOX. E- typical FACS
scan profiles for cells incubated in the ab-
sence (C) or the presence of 100 μM DCA
(DCA). NC: negative control of cells not
added with MitoSOX. F- -Kinetics of
MitoSOX fluorescence of cells incubated in
the presence of DCA. G- MitoSOX fluores-
cence in cells incubated without or with
DCA and in the absence or presence of
5 μMEC for 2 h. Results are shown as
mean ± SEM of 4–5 independent experi-
ments. Data were normalized to control
values. Kinetic graphs: control values are
shown as a dashed grey line. *Significantly
different from controls at the corresponding
time point. Bars: values having different
superscripts are significantly different
(p < 0.05, One-way ANOVA). (For inter-
pretation of the references to color in this
figure legend, the reader is referred to the
Web version of this article.)
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Consistently, EC prevented high-fat diet-induced intestinal permeabi-
lization and NADPH oxidase upregulation in mice [20]. EC, which has a
structural similarity to apocynin, also directly inhibits NADPH oxidase
activity in vascular endothelial cells [30], and in Caco-2 cells [19,20].
On the other hand, while DCA increased mitochondrial ROS produc-
tion, EC had no preventive effects. Thus, the above findings stress a
relevant role for NADPH oxidase in DCA-mediated epithelial monolayer
permeabilization, and this enzyme as a target of EC in the protection of
GI barrier function.
Both NF-κB and ERK1/2 are major players in the regulation of TJ
structure and dynamics. Under the current experimental conditions,
100 μM DCA did not affect NF-κB but promoted the activation of ERK1/
2 in Caco-2 cells. ERK1/2 activation by DCA was previously described
in hepatocytes [31,32] and intestinal cells [15,33]. This activation can
be triggered by the interactions of DCA with the cell membrane, pro-
motion of membrane physical alterations, and the associated activation
of membrane proteins, i.e. the EGFR and cell membrane NADPH oxi-
dases [12,13,15,19,32,34]. In fact, we observed that DCA activated the
EGFR and downstream the ERK1/2 pathway. Our findings that EC,
VAS-2870, apocynin and the MEK inhibitor U0126 inhibit both ERK1/2
activation and Caco-2 monolayer permeabilization establishes a causal
link between NADPH oxidase and ERK1/2 activation in DCA-induced
increase in monolayer paracellular transport.
Phosphorylation of MLC is a required step in the physiological
opening of the TJ and is regulated by its phosphorylation by MLCK and
dephosphorylation by MLC phosphatase. DCA increased MLC phos-
phorylation that was inhibited by EC and by NADPH oxidase and ERK1/
2 inhibitors. ERK1/2 modulates MLCK expression by phosphorylating
the ETS domain-containing protein ELK-1. Phosphorylated ELK-1 sub-
sequently binds to the promoter of the MLCK gene increasing its tran-
scription [16]. However, we did not observe an upregulation of MLCK
by DCA indicating that this is not the mechanism causing increased
MLC phosphorylation. On the other hand, the activity of MLC phos-
phatase is regulated by phosphorylation of the MYPT1 regulatory
subunit at threonine 696 and 853. This is done by the kinases ERK1/2
and ROCK, leading to the inhibition of MLCP activity [35–37]. DCA
increased MYTP phosphorylation which was inhibited by EC and the
NADPH oxidase and ERK1/2 inhibitors. This suggests that the inhibi-
tion of MLCP is one mechanism involved in DCA/ERK1/2-mediated
increased levels of phosphorylated MLC in Caco-2 cells, and consequent
monolayer permeabilization.
Other adverse effect of bile acids is the downregulation of TJ pro-
teins. In rodents chronically fed a high-fat diet there is a decreased
expression of TJ proteins including ZO-1, occludin, claudin-1, claudin-
Fig. 4. ERK1/2 activation is involved in
DCA-induced Caco-2 cell monolayer per-
meabilization: inhibitory actions of EC
and other NADPH oxidase inhibitors.
Caco-2 cell monolayers were incubated for
0–4 h with or without 100 μM DCA in the
absence or the presence of 5 μMEC, 1 μM
apocynin, 1 μM VAS-2870 or 10 μM U0126.
A- The kinetics of ERK1/2 and NF-κB acti-
vation in the presence of 100 μM DCA was
evaluated by Western blot by measuring the
phosphorylation of ERK1/2 (T202/Y204)
and p65 (Ser536), respectively. B- Cells
were incubated with or without 100 μM
DCA and in the absence or the presence of
1 μMEC for either 0.5 h to assess EGFR
phosphorylation (Tyr1068) or 2 h for ERK1/
2 phosphorylation. C,D- Cells were in-
cubated with or without 100 μM DCA and in
the absence or the presence of apocynin,
VAS-2870 or U0126 for 2 h. C,D- Effects of
the NADPH oxidase and ERK1/2 inhibitors
on (C) DCA-induced ERK1/2 phosphoryla-
tion measured by Western blot, and (D)
Caco-2 cell monolayer permeabilization
evaluated as the FITC-dextran paracellular
transport. Western blot bands were quanti-
fied and values for phosphorylated proteins
were referred to the respective total protein
content. Results are shown as mean ± SEM
of 4–6 independent experiments. A-
*Significantly different from controls at the
corresponding time point. B-D- Values
having different superscripts are sig-
nificantly different (p < 0.05, One-way
ANOVA).
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3, and junctional adhesion molecule-1 [11,20]. Accordingly, bile juice
isolated from rats fed a high-fat diet promoted Caco-2 cell monolayer
permeabilization and the downregulation of claudin-1, claudin-3, and
junctional adhesion molecule-1 [11]. DCA-treated Apcmin/+ mice also
show a decreased expression of ZO-1 [38]. We observed that DCA de-
creased the protein content of ZO-1 and occludin, which was prevented
by EC, and both NADPH oxidase and ERK1/2 inhibitors. On the other
hand, the EC isomer (+)-catechin did not prevent inflammation-in-
duced decrease in ZO-1 and occludin expression and consequent
monolayer permeabilization [39]. This stresses the critical importance
of the stereospecificity of flavonoids on their biological actions. Me-
talloproteinases have been found to be involved in the degradation of
TJ proteins [40]. The activation of MMP-9 and MMP-2 was found to be
responsible for the low levels of ZO-1, occludin and JAM-A in choles-
terol oxidation products-treated Caco-2 cells [41]. Consistently, EC and
NADPH oxidase and MEK/ERK inhibitors prevented DCA-mediated
MMP-2 activation. Accordingly, ERK1/2 regulates the expression of
MMP-2. MEK1 constitutive activation causes increased MMP-2 and
MMP-9 activity and decreases ZO-1 and occludin levels in intestinal
epithelial cells [42]. Thus, the protection of TJ structure via
downregulation of MMP-2 is another mechanism involved in EC-
mediated protection against the adverse effects of DCA.
We conclude that bile acids play a central role in high-fat diet-in-
duced intestinal permeabilization. The capacity of EC supplementation
to prevent high-fat diet-induced permeabilization and endotoxemia in
mice can be in part explained by its preventive effects on bile acid-
induced loss of TJ structure and function. Evidence suggest that EC acts
in part preventing NADPH oxidase upregulation, increased oxidant
production, and the activation of the redox-sensitive ERK1/2 signaling
pathway. Through these mechanisms, diets rich in EC can contribute to
protect the gastrointestinal tract from the adverse effects of high fat
consumption.
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Fig. 5. DCA promotes an increase in MLC
phosphorylation independently from
MLCK but dependent on MLC phospha-
tase inhibition: effects of EC, and NADPH
oxidase and ERK1/2 inhibitors. Caco-
2 cell monolayers were incubated for 2 h
with or without 100 μM DCA and in the
absence or the presence of 5 μMEC, 1 μM
apocynin, 1 μM VAS-2870 or 10 μM U0126.
(A) MLC (Ser19) and (D) MYPT1 (Thr696)
phosphorylation levels were measured by
Western blot. After quantification values for
phosphorylated proteins were referred to
the respective total protein content. β-actin
was measured as loading control. B,C-
MLCK mRNA levels were measured by RT-
PCR and values referred to the β-actin
mRNA content. B- Kinetics of DCA-medi-
ated effects on MLCK mRNA levels, C-
Effects of the inhibitors on the MLCK mRNA
content after 2 h incubation with DCA.
Results are shown as mean ± SEM of 4–6
independent experiments. Values having
different superscripts are significantly dif-
ferent (p < 0.05, One-way ANOVA).
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